Ben Richardson, CEO at SulNOx, confident they can cost-effectively decarbonise commercial shipping. Watch the video here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
wonder if i put a order to buy £250k worth what will that do to the price, not that i will but it will certainly cause the price to go crazy. il buy in for a punt cannot buy even £500 worth, with few amount of shares could be a nice run upto 1p
MARKET CAP £480,000 i could buy this whole company.
Now where have we heard talk like this before, sucking in suckers? Venn Life Sciences (AIM: VENN), a growing Clinical Research Organisation (CRO) providing clinical trial management and resourcing solutions to pharmaceutical, biotechnology and medical device clients, announces the acquisition of the intellectual property rights in Labskin™, SYN1113 and related equipment of Evocutis plc, for £210,000 in new ordinary shares in Venn. Evocutis plc is a dermatology company that has developed an innovative skin substitute product called LabSkin™, which provides an alternative to animal testing. LabSkin™ looks, feels and behaves just like human skin and displays a barrier function similar to that of human skin. Since March 2013, it has become illegal to sell skincare or cosmetic products within the European Union that have been tested on animals. The Board of Venn believes that this regulatory change has opened a significant market opportunity for LabSkin™. Venn is acquiring the intellectual property and know-how to produce LabSkin™, perform the specialised portfolio of contract research assays, in vitro skin models, skin microbiology expertise and clinical trial support services all focused entirely on dermatology. In addition, Venn will acquire the novel anti-acne compound SYN1113, which is a clinically proven and patented technology. Venn will out-license this technology through its division InnoVenn. The consideration for this transaction will be £210,000, to be satisfied by new ordinary shares in the share capital of Venn calculated in accordance with the Disposal Agreement, a royalty of 7.5% on the gross sales of LabSkin™ for 3 years from date of acquisition, and a royalty of 25% on the future sale of or out-licence agreements for SYN1113. The completion of the acquisition, which is conditional upon the shareholders of Evocutis plc approving the disposal of the intellectual property rights, is expected on 13 March 2014. Commenting on the acquisition, Tony Richardson, CEO of Venn, said: "The acquisition of these ready to market innovative products and capabilities, which have the benefit of over ten years of research, further enhances our credibility in the area of skin science. In December 2013, we acquired CRM Clinical Trials GmbH, a CRO with a strong pedigree in the dermatology and skin science arena. The acquisition of these assets will allow us to deepen our capabilities in the skincare and cosmetic arena and position Venn as a key player in this sector.
Someone showing some confidence.
for reverse takeover, 210k in shares that can be sold after 6 months and a nice little income stream. There will aslo be some nice tax advantages for an incoming company. Check out VIY as similar proposition to this, they have an excellent Director appointed there.
I expect 13th March will pass the resolutions and then new directors appointment announced around the AGM. I expect this has already be planned out as change of adviser would likely have an input. New board and then a new direction. There is no guarantee here but very minimal downside at current market capital. It would be great if we could reverse into a decent BIO looking for a cheap listing.
Absolutely agree mate... Good luck to those who decide to hold, I have noted the names of the directors and will not put money into any company with which they are associated.... There are lots of dodgy aim firms and directors.. I have a list of others and as that list gets longer, the relative successes of my investments seem to be getting more regular... It does seen that the same names crop up time after time when it comes to poor investments... This to me is an absolute turd whilst these people are in charge... All this nonsense about knowing months /years ago about difficult conditions smacks of ostriches burying their heads and hoping for the best.. Not the way I want to see my investments being managed... I am aiming for pro active companies where if something isn't working then it is changed quickly not left to hope and magic... Good luck tho to the holders, you will need it..!
Sometimes cash shells work and sometimes they do not - depends on whether new shares will be issued and at what price. Hard to value this share on future prospects until matters are clearer but at 0.25p you would presume little downside left? The MMs obviously do not want much trade either judging by the spread...
I respect our opinion but it will be a different BOD bought in to run this. I expect a new director/s appointment made after resolutions are passed on 13th March. This is now a clean shell with possible income stream. Let's see who gets appointed to run this show a go from there.
could well be... frankly, whatever happens from here will be a bonus. At least the company did not go into administration. Mark my words, Tom Bannatyne is not going to kiss goodbye to his investment just yet. He'll want to see some sort of return and (on the back iof it) so should we
I feel there might be a future investment already lined up with recent change of NOMAD to Cairn.
I agree - time to shut these firmly in bottom drawer and come back in 6 months or a year :)
We are selling to a listed company and receiving shares as payment with a 6 month lock in. There is also an on going royalty payment. We should see a decent increase in sp from here
it's gone for 200ks worth of shares in the new holders' company. Interesting to see they are still using the same excitable marketing langauge that sucked us all in this time last year... in the run-up to the impsotion of the EU ban on animal testing. Hindsight is a wonderful thing...
ANY shareholders who go to that meeting are going to vote against re-appointing any if those directors for a start... And against their proposed remuneration plans to squeeze more cash out of this shrivelling cow.... I would also hope that the use of foul language and the shaking of fists and perhaps the throwing of the odd chair will finally get it through to these morons that the time for them to go is well (well) overdue.... Quite clearly the labskin is going to be sold to the spinoff company started by the 2 docs.... Probably for peanuts... Any sale will need them to be involved anyway as they know the tech...
does that mean my 4000 shares here might, one day, be worth more that a tenner, lol!
Still banging on about "shareholder value" whilst the company is going to the wall.
The BOD led us all up the garden path, they lack morals, scruples and most of all integrity. I bet they can't even lie straight in bed at night. After what they have done to people like MF and Baker, I don't know how they can even sleep.
://.evocutis.com/userfiles/press-releases/gmnotice250214.pdf here a summary of it, Following a review of the performance of the busine ss, the Board has concluded that the performance of the Company is not strong enough to secure an in dependent future. The Directors are therefore proposing to dispose of the Company’s intellectual property rights in LabSkin ™ and SYN1113, and related assets. Completion will d ivest the Company of substantially all of its assets and the Company will be treated as an In vesting Company, as a consequence under Rule 15 of the AIM Rules. The following announcement has b een extracted from the Circular (without material adjustment) which is available on the Company’s web site, and outlines the key details including the proposed Investing Policy. Tom Bannatyne, Chairman of the Company commented; “ The Board of Evocutis recognised the difficult position the Company was in late in 2012. Since then we have spent considerable effort to identify, review and evaluate all strategic options available. The Directors consider the Proposals to be in the best interests of the Company and the Sha reholders as a whole. Going forward, the Company will be open to a variety of potential investments which the Directors believe will provide exciting prospects and real opportunity to create shareholde r value“.
My son was two last time we flew. He's five this year, and we haven't been on a plane since as it was that traumatic.. However ... I defo need some sun this year so hopefully he will behave... Soooo stressful
Yes, I did fly. First time with my 2 year old.....harder than I thought it would be as he wanted to "explore" his surroundings!
That's brilliant news... Best of luck with that guys.. By the way Dr B your totally rocking the beardy look.... Very Russel Crowe ;)
Looks like Drs Bojar and Jeremy have now left EVO completely and set up a new company http://www.sstba.co.uk/
Hi astro... Good holiday? Did you fly?? It was windy !! Dr bs I think, that trade matched his holding exactly .
Been busy on here since I've last posted? What's going on here then? Some pretty big trades since I last checked. Was that 11m a buy or sell?